These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 22870788)

  • 1. Expression of IFNAR2 mRNA in peripheral blood mononuclear cells of patients with HCV infection.
    Liu N; Wen Y; Sun C; Liu P
    Acta Gastroenterol Belg; 2012 Jun; 75(2):228-33. PubMed ID: 22870788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type I interferon receptor and response to interferon therapy in chronic hepatitis C patients: a prospective study.
    Fujiwara D; Hino K; Yamaguchi Y; Kubo Y; Yamashita S; Uchida K; Konishi T; Nakamura H; Korenaga M; Okuda M; Okita K
    J Viral Hepat; 2004 Mar; 11(2):136-40. PubMed ID: 14996348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presence of hepatitis C virus (HCV)-RNA in peripheral blood mononuclear cells in HCV serum negative patients during interferon and ribavirin therapy.
    Januszkiewicz-Lewandowska D; Wysocki J; Pernak M; Nowicka K; Zawada M; Rembowska J; Lewandowski K; Mańkowski P; Nowak J
    Jpn J Infect Dis; 2007 Feb; 60(1):29-32. PubMed ID: 17314422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid virological response in peripheral blood mononuclear cells with an increase of hepatitis C virus-specific interferon-gamma production predisposes to sustained virological response in patients with chronic hepatitis C genotype 1 undergoing treatment with pegylated-interferon alpha 2a plus ribavirin.
    Perrella A; Sbreglia C; Atripaldi L; Esposito C; D'Antonio A; Perrella O
    Scand J Gastroenterol; 2010; 45(2):250-5. PubMed ID: 19968615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C viral kinetics in plasma and peripheral blood mononuclear cells during pegylated interferon-alpha2a/ribavirin therapy.
    Pugnale P; Herrmann E; Neumann AU; Pawlotsky JM; Schalm SW; Ferrari C; Homburger Y; Zeuzem S; Negro F;
    J Hepatol; 2008 Jun; 48(6):932-8. PubMed ID: 18433918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon-alpha receptor 1 mRNA expression in peripheral blood mononuclear cells is associated with response to interferon-alpha therapy of patients with chronic hepatitis C.
    Massirer KB; Hirata MH; Silva AE; Ferraz ML; Nguyen NY; Hirata RD
    Braz J Med Biol Res; 2004 May; 37(5):643-7. PubMed ID: 15107924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of IFN-alpha/beta receptor in the PBMCs and liver of patients with hepatitis B and its clinical significance].
    Fan HB; Guo YB; Wang BJ; Zhu YF; Wu AH; Hou JL; Yang DL
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):979-81. PubMed ID: 18583243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic interferon receptor mRNA expression: clinical relevance and its relationship with effectiveness of interferon plus ribavirin therapy in patients with genotype 1b hepatitis C virus infection.
    Lee CM; Kee KM; Hung CH; Eng HL; Chang CH; Huang CM; Wang JH; Hu TH; Lu SN; Changchien CS; Chen WJ
    Antivir Ther; 2006; 11(1):17-23. PubMed ID: 16518956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations between human TRIM22 gene expression and the response to combination therapy with Peg-IFNα-2a and ribavirin in Iranian patients with chronic hepatitis C.
    Sadeghi F; Bokharaei-Salim F; Salehi-Vaziri M; Monavari SH; Alavian SM; Salimi S; Vahabpour R; Keyvani H
    J Med Virol; 2014 Sep; 86(9):1499-506. PubMed ID: 24889558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of microRNA-155 precursor in peripheral blood mononuclear cells from Hepatitis C patients after antiviral treatment.
    Sidorkiewicz M; Grek M; Jozwiak B; Majda-Stanislawska E; Piekarska A; Bartkowiak J
    Acta Virol; 2010; 54(1):75-8. PubMed ID: 20201617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of molecular parameters for routine assessment of viremia in patients with chronic hepatitis C who are undergoing antiviral therapy.
    Kessler HH; Pierer K; Santner BI; Vellimedu SK; Stelzl E; Marth E; Fickert P; Stauber RE
    J Hum Virol; 1998; 1(5):314-9. PubMed ID: 10195258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis.
    Petit JM; Benichou M; Duvillard L; Jooste V; Bour JB; Minello A; Verges B; Brun JM; Gambert P; Hillon P
    Am J Gastroenterol; 2003 May; 98(5):1150-4. PubMed ID: 12809841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of interferon receptor genes (IFNAR1 and IFNAR2 mRNA) in the liver may predict outcome after interferon therapy in patients with chronic genotype 2a or 2b hepatitis C virus infection.
    Morita K; Tanaka K; Saito S; Kitamura T; Kondo M; Sakaguchi T; Morimoto M; Sekihara H
    J Clin Gastroenterol; 1998 Mar; 26(2):135-40. PubMed ID: 9563926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of interferon alfa and ribavirin treatment on hepatitis C virus RNA in serum and peripheral blood mononuclear cells in children with chronic hepatitis C.
    Majda-Stanisławska E; Bednarek M; Jóźwiak B; Sidorkiewicz M; Piekarska A; Kuydowicz J
    Acta Gastroenterol Belg; 2006; 69(2):187-90. PubMed ID: 16929613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of interferon therapy on hepatitis C virus RNA in whole blood, plasma, and peripheral blood mononuclear cells.
    Schmidt WN; Wu P; Brashear D; Klinzman D; Phillips MJ; LaBrecque DR; Stapleton JT
    Hepatology; 1998 Oct; 28(4):1110-6. PubMed ID: 9755250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human cytomegalovirus infection inhibits response of chronic hepatitis-C-virus-infected patients to interferon-based therapy.
    Bader el-Din NG; Abd el-Meguid M; Tabll AA; Anany MA; Esmat G; Zayed N; Helmy A; el-Zayady AR; Barakat A; el-Awady MK
    J Gastroenterol Hepatol; 2011 Jan; 26(1):55-62. PubMed ID: 21175794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A potent antiviral effect on hepatitis C viral dynamics in serum and peripheral blood mononuclear cells during combination therapy with high-dose daily interferon alfa plus ribavirin and intravenous twice-daily treatment with interferon beta.
    Asahina Y; Izumi N; Uchihara M; Noguchi O; Tsuchiya K; Hamano K; Kanazawa N; Itakura J; Miyake S; Sakai T
    Hepatology; 2001 Aug; 34(2):377-84. PubMed ID: 11481623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA-HCV viral load in serum, peripheral blood mononuclear cells and liver in children with chronic hepatitis C.
    Kowala-Piaskowska A; Mozer-Lisewska I; Januszkiewicz-Lewandowska D; Michalak M; Zeromski J; Madaliński K; Słuzewski W
    Acta Pol Pharm; 2012; 69(5):859-63. PubMed ID: 23061281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virological pattern in plasma, peripheral blood mononuclear cells and liver tissue and clinical outcome in chronic hepatitis B and C virus coinfection.
    Coppola N; Pisapia R; Tonziello G; Martini S; Imparato M; Piai G; Stanzione M; Sagnelli C; Filippini P; Piccinino F; Sagnelli E
    Antivir Ther; 2008; 13(2):307-18. PubMed ID: 18505182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of toll-like receptors 2 and 4 mRNA expression in chronic hepatitis C virus infection.
    Shehata MA; Abou El-Enein A; El-Sharnouby GA
    Egypt J Immunol; 2006; 13(1):141-52. PubMed ID: 17974158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.